Vancouver, British Columbia--(Newsfile Corp. - May 12, 2015) - SeeThruEquity, a leading independent equity research firm, has identified significant short selling activity on OxySure Systems (OTCQB: OXYS). According to data compiled by Buyins.net, between November 18, 2014 and April 30, 2015, approximately 5.7 million shares of OxySure have been sold short.

InvestmentPitch.com has produced a "video news alert" which provides a brief overview of the company. If this link is not enabled, please visit www.InvestmentPitch.com and enter "OxySure" in the search box.


If you cannot view the video above, please visit:
http://www.investmentpitch.com/video/0_bot5fgen/SeeThruEquity-identifies-significant-short-selling-activity-on-OxySure-Systems-OTCQB-OXYS

The data suggests that nearly ¾ of the float has been sold short during this time period, representing 36% of the total volume of 15.9 million shares traded.

SeeThruEquity analyst Ajay Tandon stated: "Considering that the float in OxySure Systems is just 7.65 million of the total 29.6 million shares outstanding, we find this data eye-opening. If a short position of this magnitude were outstanding in its entirety then it would take more than 2 months of buying to cover at the current average daily trading volume, which averages less than 100,000 shares per day."

SeeThruEquity currently has a price target of $2.30 on OxySure, a significant premium to the current $0.72 price, calling the company an intriguing speculative medical device company entering what should be a significant growth year, with an innovative product targeting a large potential market.

OxySure, a medical technology company, focusses on the design, manufacture and distribution of specialty respiratory and medical solutions. The company pioneered a safe and easy to use solution to provide medically pure oxygen from inert powders, and owns numerous patents on this technology. By making it possible for lay persons to administer medical oxygen during those first, critical minutes after a medical emergency, providing initial stabilization while waiting for professional first responders to arrive, improved outcomes have been observed in thousands of cases.

On May 5th, CEO Julian Ross provided a compelling corporate update on the company, highlighting several initiates that SeeThruEquity considered important and necessary steps for the company to achieve its growth plan of reaching a revenue run rate of $10 million by the end of 2015.

For more information, please visit the company's website www.oxysure.com.

In Canada, investor relations is handled by Bettina Filippone of Remark Financial Communications (bfilippone@renmarkfinancial.com) and in the US, please contact Jon Cunningham at Redchip Companies (jon@redchip.com).

About InvestmentPitch

InvestmentPitch.com, a multimedia company that provides a combined solution for creating and hosting financial video content, and distributing it across multiple platforms to investors and financial professionals, specializes in producing short three minute videos based on significant news releases and research reports.

CONTACT:
InvestmentPitch.com
Barry Morgan, CFO
bmorgan@investmentpitch.com